Related Experiment Video

Updated: Nov 29, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

878

Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research

Adrienne P Savant1,2, Susanna A McColley3,4,5

  • 1Division of Pulmonary Medicine, Children's Hospital of New Orleans, New Orleans, Louisiana, USA.

Pediatric Pulmonology
|November 19, 2020
PubMed

Insights

This review summarizes 2019 research on cystic fibrosis (CF) care, focusing on multisystem manifestations. It highlights advancements in CF management and treatment for patients and families.

Area of Science:

  • Medical Research
  • Pulmonology
  • Genetics

Background:

  • 2019 saw significant research publications relevant to cystic fibrosis (CF) care.
  • This article is the third in a series reviewing CF advancements.
  • Previous reviews covered CFTR modulators and pulmonary/airway disease.

Purpose of the Study:

  • To provide an overview of key research from 2019 concerning cystic fibrosis.
  • To focus on the multisystem aspects of CF care.
  • To inform healthcare professionals and families about recent developments.

Main Methods:

  • Literature review of research published in 2019.
  • Synthesis of findings related to multisystem manifestations of CF.
  • Categorization of studies based on previous review topics (modulators, pulmonary, infections).

Main Results:

  • Numerous studies offer valuable insights for CF professionals and families.
  • Focus on the broad impact of CF beyond the lungs.
  • Integration of findings from prior reviews on modulators and pulmonary disease.

Conclusions:

  • The year 2019 yielded important research for comprehensive CF care.
  • Understanding multisystem involvement is crucial for improving patient outcomes.
  • Continued research is vital for advancing the care of individuals with CF and their families.

Keywords:
cystic fibrosisnewborn screennutritionpsychosocialsurvival

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

333
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

903

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
319
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
577
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
189
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
906
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
225